U.S. court grants exclusivity for Amarin's Vascepa
May 28, 2015 at 14:26 PM EDT
May 28 (Reuters) - A U.S. district court has ruled that Amarin Corp's fish oil pill, Vascepa, is eligible for five years of marketing exclusivity, setting aside a U.S. Food and Drug administration decision.
